4//SEC Filing
Cole Douglas G. 4
Accession 0001415889-21-003236
CIK 0001821323other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 7:15 AM ET
Size
5.3 KB
Accession
0001415889-21-003236
Insider Transaction Report
Form 4
Cole Douglas G.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24$9.97/sh+8,888$88,613→ 8,888 totalExercise: $9.97Exp: 2031-06-23→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on June 24, 2022.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001486373
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 7:15 AM ET
- Size
- 5.3 KB